(NASDAQ:ALAR),(TASE:ALAR.TA), TEL AVIV, Israel, Nov. 26, 2025 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of web data collection solutions, today announced financial results for the nine- and three-month periods ended September 30, 2025. Financial Highlights Q3 2025 revenues of $13.0 million, up 81% year-over-year; net profit […]

New Habit Restaurant to Open Doors on December 3Hold Pre-Opening VIP Events on December 1-2 IRVINE, Calif., Nov. 26, 2025 (GLOBE NEWSWIRE) — Habit, the California-based restaurant company renowned for its award-winning Charburgers grilled over an open flame, signature sandwiches, fresh salads, and more, announces today the launch of their first restaurant in Oregon with

(NASDAQ:AVXL), NEW YORK, Nov. 26, 2025 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, today announced that it will present

(TSX-V:ARGH),(OTC US:ARGHF),(OtherOTC:ARGHF), TORONTO, Nov. 26, 2025 (GLOBE NEWSWIRE) — Argo Corporation (TSXV:ARGH) (OTCQX:ARGHF) (“Argo” or the “Company“), a leader in next-generation transit solutions, today announced the launch of its Smart Routing(TM) pilot service in the City of Brampton. Argo connects to existing Brampton Transit routes with an on-demand, fully electric service and integrates with the

(NasdaqGM:ALT), GAITHERSBURG, Md., Nov. 26, 2025 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that members of the Company's management team will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference. Details are as follows: Conference:

(NASDAQ:RGEN), WALTHAM, Mass., Nov. 26, 2025 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participate in the 8th Annual Evercore Healthcare Conference, being held December 2 -4 in Coral Gables, Florida. Jason Garland, Chief Financial Officer, will participate in an analyst-led discussion

(NASDAQ:BNTX), Offer set to expire at 9:00 am Eastern Time on December 3, 2025, with CureVac shareholders advised to tender their shares by 6:00 pm Eastern Time on December 2, 2025, due to operational deadlines. Exchange ratio of 0.05363 of a BioNTech American Depositary Share (“ADS”) for each CureVac share, determined based on the volume-weighted

(NasdaqGM:SLXN), Grand Cayman, Cayman Islands, Nov. 26, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (“Silexion” or the “Company”), a clinical-stage, oncology-focused biotechnology company, today announced that Company management will be attending and presenting at the Noble Capital Markets' 21st Annual Emerging Growth Equity Conference (NobleCon21). Presentation details:Type: Company presentationDate: December 3, 2025Time: 2:30 – 2:55pm

DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”), is pleased to announce that its venture portfolio company Canada Stablecorp Inc. (“Stablecorp”) and the QCAD Digital Trust have achieved a significant national milestone, with

— Expansion ofrhCollagen and BioInk raw material sales in North American territories expected through a new partnership with a U.S.-based logistics center scheduled to become operational this quarter and under new commercial leadership for this region — Recent developments suggestCollPlant's rhCollagen will have a significant contribution towards innovation in the areas of non-animal alternatives for